MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 11.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,028,729 shares of the company's stock after buying an additional 109,265 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.08% of Keurig Dr Pepper worth $35,203,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Keurig Dr Pepper by 21.3% during the 1st quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company's stock worth $4,962,338,000 after acquiring an additional 25,425,644 shares during the period. JPMorgan Chase & Co. increased its position in Keurig Dr Pepper by 108.1% in the 1st quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company's stock valued at $1,330,565,000 after acquiring an additional 20,196,835 shares during the period. T. Rowe Price Investment Management Inc. increased its position in Keurig Dr Pepper by 981.3% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,514,608 shares of the company's stock valued at $86,050,000 after acquiring an additional 2,282,050 shares during the period. Seven Grand Managers LLC acquired a new position in Keurig Dr Pepper in the 1st quarter valued at approximately $51,330,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Keurig Dr Pepper by 15.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 9,260,957 shares of the company's stock valued at $297,462,000 after acquiring an additional 1,258,062 shares during the period. Institutional investors own 93.99% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the stock. Barclays upped their price target on shares of Keurig Dr Pepper from $37.00 to $39.00 and gave the company an "overweight" rating in a research report on Monday, July 28th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research report on Tuesday, August 26th. UBS Group reduced their price objective on shares of Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating on the stock in a research note on Wednesday, August 27th. Hsbc Global Res lowered shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a research note on Thursday, July 17th. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $38.38.
Get Our Latest Report on Keurig Dr Pepper
Keurig Dr Pepper Stock Down 1.7%
NASDAQ KDP traded down $0.47 on Friday, hitting $27.12. 5,905,912 shares of the company were exchanged, compared to its average volume of 13,214,309. The company has a market cap of $36.84 billion, a PE ratio of 24.20, a PEG ratio of 1.50 and a beta of 0.47. Keurig Dr Pepper, Inc has a 12 month low of $27.08 and a 12 month high of $38.28. The stock has a fifty day moving average of $32.47 and a 200-day moving average of $33.32. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.49. The business had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. Keurig Dr Pepper's revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.45 earnings per share. As a group, analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Insider Buying and Selling at Keurig Dr Pepper
In related news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the transaction, the insider directly owned 82,511 shares of the company's stock, valued at $2,777,320.26. This represents a 12.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert James Gamgort sold 208,000 shares of the stock in a transaction on Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the transaction, the director directly owned 2,292,169 shares in the company, valued at approximately $75,412,360.10. This represents a 8.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 459,601 shares of company stock worth $15,228,872. 0.40% of the stock is owned by insiders.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report